All Categories
6 months ximaging powers the largest ai robotic lab in china-0

News

Home >  News

6 Months! Ximaging Powers the Largest AI Robotic Lab in China

Jan 09, 2025

On the afternoon of Feb 29th 2022, Insilico Medicine, a biotech firm driven by an end-to-end AI platform, held the "Life Star 6th Gen Intelligent Robotic Lab Launch" at Suzhou's BioBAY. The fully-automated, AI robotic lab was officially opened, marking the full-scale application of Ximaging biopharma automation solutions.

This robotic lab features an automated solution developed by Ximaging. It can run multiple functional islands independently or in series, optimizing experiment timelines and enabling intelligent control. Focused on target discovery, compound screening, personalized drug discovery, and translational medicine, it aims to revolutionize drug discovery, boost pharmaceutical developing success rate, and speed up meeting unmet clinical needs.

Launch Ceremony of Insilico's Suzhou Lab

Dr. Jiapeng Liu, founder and CEO of Ximaging, and Dr. Evelyne Bischof, an associate chief physician at Renji Hospital (affiliated to Shanghai Jiaotong University), were invited to share insights on "New Tech Empowering Biopharma". Yingyu Liang (Qiming Venture Partner), Cai Wei (Bosten Capital China), Xiaolong Yang (Sinovation Ventures partner), Cai Xiang (board director and general manager of Prosperity7 Ventures), Wu Jing (Executive General Manager of CPE Yuanfeng), and Dr. Yu Tao (Executive Director, Eli Lilly Asia Fund) sent their congratulations by video.

1.png

At the ceremony, Dr. Liu Jiapeng recapped the R&D journey.

Automation in biopharma is widespread, from high - throughput screening to automated modules and machine - learning data generation. The 5th-gen biolabs are fully automated, bias free, process integrated, and can produce quality data for machine learning. Insilico Medicine has gone further, integrating AI-assisted decision - making with automation, robotics, and biology to create a new-gen robot lab. Ximaging's solution enables intelligent operations in cell culture, nucleic acid ID, high - throughput drug screening, NGS sample prep, protein purification, and LCMS sample pre-treatment, creating a truly unmanned lab and leading the biopharma R& D automation revolution.

 

Ximaging Builds fully-automated AI Robotic Lab for Insilico

2.png

Dr. Alex Zhavoronkov, Insilico's founder and CEO, said, "There are many automation suppliers, but few offer end-to-end solutions. Ximaging has a large robot-integrating team. After six months of tough screening, it stood out against another big Chinese firm and became our key partner for the 6th gen lab, helping us integrate robots and automated equipment. Without Ximaging, this AI lab wouldn't exist.

I saw their team's heroic efforts to meet the launch deadline. Despite the 2022 Shanghai lockdown due to COVID, they still delivered on time. The close teamwork between Insilico and Ximaging overcame this tough challenge. It's remarkable. "

Dr. Liu Jiapeng said, "At the start of 2022, we were glad to congratulate Insilico on opening its Suzhou lab. Huixiang is honored to help build this fully automated, AI lab.

The 6th-gen lab was a global first. When we signed the contract, we knew it was the largest and most complex project in Chin, a huge challenge for us. But over the year, our team overcame lockdowns, supply-chain issues, and tight schedules. We worked together and delivered this project successfully, capping the year 2022 perfectly. We believe with the blessing of this 6th-gen AI lab, Insilico's drug discovery efficiency will be further improved, quickly meeting clinical needs, and benefiting many patients. "

3.png

The largetst, most complicated, fully-automated AI robotic lab in China, offically contracted

Over the year, Ximaging and Insilico joined forces to overcome all these obstacles.

4.png

FAT delivery acceptance test started

6.png

Full line debugging after the second delivery.Whole network coordinated commissioning successfully done by Ximaging team.

About Ximaging

Ximaging combines AI with life sciences and high-throughput experiments,devoted to comprehensive automated and intelligent solutions for biochemistry, pharma, and safety testing, from molecules to cells. Its products include intelligent robotic workstations (from food/drug safety to life sciences), full workflow automated testing,intelligent integrated systems, and related equipment and consumables.We are commmited to be a global provider of life health automation and intelligence solutions, ensuring everyone enjoys a healthy, safe and quality life.